ArticleTransplantation direct2023

Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial.

Aileen C Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.